Cargando…
Peripheral T cell lymphoma, not otherwise specified: the stuff of genes, dreams and therapies
Peripheral T cell lymphomas (PTCL) account for about 12% of lymphoid tumours worldwide. Almost half show such morphological and molecular variability as to hamper any further classification, and to justify their inclusion in a waste-basket category termed “not otherwise specified (NOS)”. The latter...
Autores principales: | Agostinelli, C, Piccaluga, P P, Went, P, Rossi, M, Gazzola, A, Righi, S, Sista, T, Campidelli, C, Zinzani, P L, Falini, B, Pileri, S A |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2582342/ https://www.ncbi.nlm.nih.gov/pubmed/18755717 http://dx.doi.org/10.1136/jcp.2008.055335 |
Ejemplares similares
-
Pathogenetic and diagnostic significance of microRNA deregulation in peripheral T-cell lymphoma not otherwise specified
por: Laginestra, M A, et al.
Publicado: (2014) -
Peripheral T Cell Lymphoma: Not Otherwise Specified
por: Pai, Anusha H, et al.
Publicado: (2015) -
Peripheral T-cell lymphoma, not otherwise specified
por: Jha, Kunal Kishor, et al.
Publicado: (2017) -
Peripheral T-Cell Lymphoma, Not Otherwise Specified: Clinical Manifestations, Diagnosis, and Future Treatment
por: Pileri, Stefano A., et al.
Publicado: (2021) -
Immunohistochemical and other prognostic factors in B cell non Hodgkin lymphoma patients, Kampala, Uganda
por: Tumwine, Lynnette K, et al.
Publicado: (2009)